LLY

1,091.31

+2.27%↑

JNJ

224.22

+0.46%↑

ABBV

219.21

+2.9%↑

UNH

383.21

+2.17%↑

MRK

115.28

-0.64%↓

LLY

1,091.31

+2.27%↑

JNJ

224.22

+0.46%↑

ABBV

219.21

+2.9%↑

UNH

383.21

+2.17%↑

MRK

115.28

-0.64%↓

LLY

1,091.31

+2.27%↑

JNJ

224.22

+0.46%↑

ABBV

219.21

+2.9%↑

UNH

383.21

+2.17%↑

MRK

115.28

-0.64%↓

LLY

1,091.31

+2.27%↑

JNJ

224.22

+0.46%↑

ABBV

219.21

+2.9%↑

UNH

383.21

+2.17%↑

MRK

115.28

-0.64%↓

LLY

1,091.31

+2.27%↑

JNJ

224.22

+0.46%↑

ABBV

219.21

+2.9%↑

UNH

383.21

+2.17%↑

MRK

115.28

-0.64%↓

Home・Akciju saraksts・Neogen Corp

Neogen Corp

Atvērts

SektorsVeselības aprūpe

8.77 -0.9

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

8.59

Max

8.96

Galvenie mērījumi
By Trading Economics
Ienākumi	-1.1M -17M
Pārdošana	-13M 211M
EPS	0.09
Peļņas marža	-8.056
Darbinieki	2,974
EBITDA	2.2M 26M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+34.53% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 28. jūl.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-142M 1.9B
Iepriekšējā atvēršanas cena	9.67
Iepriekšējā slēgšanas cena	8.77

Ziņu noskaņojums

By Acuity

54%

46%

256 / 344 Rangs Healthcare

Neogen Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 2. jūn. 20:30 UTC

Peļņas

Palo Alto Networks 3Q Revenue Rises as Customers Beef Up Cyber Defenses

2026. g. 2. jūn. 23:58 UTC

Tirgus saruna

Australia's Consumer Sector Expected to Be Stung by Housing Downturn -- Market Talk

2026. g. 2. jūn. 23:46 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 2. jūn. 23:46 UTC

Tirgus saruna

Nikkei May Rise as AI Demand Hopes Continue -- Market Talk

2026. g. 2. jūn. 23:41 UTC

Tirgus saruna

Oil Rises Amid Signs of U.S.-Iran Peace Talks Stalling -- Market Talk

2026. g. 2. jūn. 23:01 UTC

Iegādes, apvienošanās, pārņemšana

ACCC Says Owner of Metro Petroleum Brand to Buy the 41 Sites

2026. g. 2. jūn. 23:01 UTC

Iegādes, apvienošanās, pārņemšana

ACCC Says Ampol Must Sell 41 Retail Fuel Sites to an Approved Purchaser

2026. g. 2. jūn. 23:00 UTC

Iegādes, apvienošanās, pārņemšana

Australia's Competition Regulator Approves Ampol's Purchase of EG Australia With Conditions

2026. g. 2. jūn. 22:57 UTC

Tirgus saruna

Australian Dollar Could Fall Following 1Q GDP Data -- Market Talk

2026. g. 2. jūn. 22:50 UTC

Tirgus saruna

Ulta Beauty Says TikTok Shop Will Provide 'Halo' Effect -- Market Talk

2026. g. 2. jūn. 21:07 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 2. jūn. 21:07 UTC

Tirgus saruna

Tokenized Assets Need Access to Digital-Finance Plumbing -- Market Talk

2026. g. 2. jūn. 21:00 UTC

Peļņas

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2026. g. 2. jūn. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 2. jūn. 20:46 UTC

Peļņas

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2026. g. 2. jūn. 20:38 UTC

Peļņas

GitLab Stock Rises as the Software Company Raises Guidance on AI Business Momentum -- Barrons.com

2026. g. 2. jūn. 20:21 UTC

Peļņas

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2026. g. 2. jūn. 20:12 UTC

Peļņas

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks 3Q Product Rev $594M

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks Sees FY26 Next-Generation Security ARR $8.9B-$8.95B

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks Raises FY26 View To Adj EPS $3.77-Adj EPS $3.79 >PANW

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks 3Q Subscription and Support Rev $2.41B

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks Sees FY26 Remaining Performance Obligation $20.9B-$21B

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks Sees 4Q Rev $3.345B-$3.355B >PANW

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks Sees 4Q Adj EPS 96c-Adj EPS 98c >PANW

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks on Track to Achieve 40% Adj Free Cash Flow Margin in FY28

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks Raises FY26 View To Rev $11.415B-$11.425B >PANW

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks 3Q Remaining Performance Obligation $18.4B

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks 3Q Adj EPS 85c >PANW

2026. g. 2. jūn. 20:05 UTC

Peļņas

Palo Alto Networks 3Q Loss $177M >PANW

Salīdzinājums

Cenas izmaiņa

Neogen Corp Prognoze

Cenas mērķis

By TipRanks

34.53% augšup

Prognoze 12 mēnešiem

Vidējais 12 USD 34.53%

Augstākais 12 USD

Zemākais 12 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Neogen Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Neogen Corp — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

256 / 344 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.